US EditionAmber Implants Announces Successful One-Year Follow-Up Data in First-in-Human Clinical Trial of VCFix® Spinal System – Ortho Spine News
Summary by Ortho Spine News | Your Trusted Voice for Medical Device Industry Ortho News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Amber Implants Announces Successful One-Year Follow-Up Data in First-in-Human Clinical Trial of VCFix® Spinal System – Ortho Spine News
– One-year follow-up data from first-in-human trial shows significant improvements in key clinical performance outcomes – This data supports a strong safety profile for the VCFix® Spinal System for the treatment of vertebral compression fractures THE HAGUE, Netherlands, June 3, 2025 /PRNewswire/ — Amber Implants, an innovative medical technology company developing next-generation implants for spinal injuries, today announces the completion of the
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
